Dr. Diego Cohen Referencias bibliográficas 1. Grant BF, Chou PS, Goldstein RB, Hunag B, Stinson FS, Saha DS. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2008;69(4):533-45. 2. American Psichiatric Association. Diagnostic and Statiscal Manual of Mental, Fourth Edition. Washington, DC: American Psychiatric Association; 1994. 3. Bradley R, Zittel Conklin J, Westen D. Borderline Personality Disorders. En: O´Donohue W, Fowler KA, Lilienfeld SO editores. Personality Disorders. Toward the DSM-V. Los Angeles: Sage Publications; 2007. p.167-201. 4. Gunderson JG. Borderline Personality Disorder. A Clinical Guide. Washington, DC: American Psychiatric Publishing;2001. 5. Gunderson JG. Disturbed relationships as a phenotype for borderline personality disorder. Am J Psychiatry 2007;164:1637-40. 6. Gabbard GO. Mind, Brain, and Personality Disorders. Am J Psychiatry 2005;162:648-55. 7) Cohen DE. Pautas para el tratamiento psicofarmacológico del transtorno límite de la personalidad (guías prácticas APA). Psicofarmacología 2009 55(9):10-7. 8. Stanley B, Siever LJ. The Interpersonal Dimension of Borderline Personality Disorder: Toward a Neuropeptide Model. Am J Psychiatry 2010;167:24-39. 9. Skodol AE, Siever LJ, Livesley WJ, Gunderson JG, Pfohl B, Widiger A.The Borderline Diagnosis II: Biology, Genetics, and Clinical Course. Biol Psychiatry 2002;51:951-63. 10. Siever LJ, Torgersen S, Gunderson JG, Livesley WJ, Kendler KS. The Borderline Diagnosis III: Identifying Endophenotypes for Genetic Studies. Biol Psychiatry 2002;51:964-8. 11. Cohen DE. Trastornos afectivos y trastorno límite de la personalidad: convergencias y divergencias. En: Zieher LM, Brió MC editores. Tratado de Psicofarmacología y Neurociencia. Vol II Parte I. Buenos Aires: Editorial Sciens;2010. p.153-80. 12. Gottesman II, Gould TD. The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions. Am J Psychiatry 2003;160:636-45. 13. Gunderson JG, Lyons-Ruth K. BPD`s Interpersonal Hypersensitivity Phenotipe: A- Gene-Enviriment-Developmental Model. J Personal Disord 2008;22(1):22-41. 14. Gunderson JG. The borderline patient´s intolerance of aloneness insecure attachment and therapist availability. Am J Psychiatry 1996;153:752-8. 15. owlby J. La pérdida afectiva. Tristeza y depresión. Buenos Aires: Paidós;1993. 16. Bowlby J. El apego y la pérdida – 1. El apego. Buenos Aires: Paidós;1998. 17. Panksepp J. Affective Neuroscience. The Foundations of Human and Animal Emotions. New York, Oxford: Oxford University Press;1998. 18. Insel T. A neurobiological basis of social attachment. Am J Psychiatry 1997;54:726-35. 19. Insel T, Winslow J. Serotonin and neuropeptides in affiliative behaviours. Biol Psychiatry 1998;44:207-19. 20. Insel T, Winslow J. The neurobiology of social attachment. in: neurobiology of mental illness. New York, Oxford: Oxford University Press;1999. p. 880-91. 21. Insel T, Young L. The neurobiology of attachment. Nat Rev Neurosci 2001;2:129-36. 22. Ainsworth M, Waters E y Wall S (1978). Patterns of attachment: a psychological study of the strange situation. Lawrence Erlbaum: New Jersey. 23. Lakatos K, Nemoda Z, Toth I, Ronai Z, Ney K, Sasvari-Szekely M et al. Further evidence for the role of the dopamine D4 receptor (DRD4) gene in attachment disorganization: interaction of the exon III 48-bp repeat the -521 C/T promoter polymorphisms.. Mol Psychiatry 2002;7(1):27-31. 24. Zieher LM. Actualización en la patofisiología de la esquizofrenia desde la perspectiva de la neurociencia de sistemas. En: Zieher LM, Brió MC editores. Tratado de Psicofarmacología y Neurociencia. Vol I. Buenos Aires: Editorial Sciens; 2009: p.73-88. 25. Agrawal HR, Gunderson JG, Holmes BM, Lyons-Ruth K. Attachment Studies with Bordeline Patients: A Review. Harv Rev Psychiatry 2004; 12(2):94-104. 26. Jang KL, Livesley WJ, Vernon PA, Jackson DN. Heritability of personality disorder traits: a twin study. Acta Med Scand Suppl 1996;94:438-44. 27. Kendler KS, Aggen SH, Czajkowski N, Roysamb E, Tambs K, Torgersen S et al. The Structure of Genetic and Environmental Risk Factors for DSM-IV Personality Disorders. Arch Gen Psychiatry 2008;65(12):1438-46. 28. New AS, Stanley B. An Opioid Deficit in Borderline Personality Disorder: Self-Cutting, Substance Abuse, and Social Dysfunction. Am J Psychiatry 2010;167:882-5. 29. Russ MJ, Shearin EN, Clarkin JF, Harrison K, Hull JW. Subtypes of Self-Injurious Patients With Borderline Personality Disorder. Am J Psychiatry 1993;150:1869-71. 30. Simeon D, Stanley B, Frances A, Mann JJ, Winchel R, Stanley M. Self-Mutilation in Personal Disorders: Psychological and Biological Correlates. Am J Psychiatry 1992;149:221-6. 31. Bohus M, Landwehrmeyer B, Stiglmary Ch, Limberger M, Bohme R, Schmal Ch. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J Clin Psychiatry 1999 60: 598- 603. 32. Prossin AR, Love TM, Koeppe RA, Zubieta J- K, Silk KR. Dysregulation of Regional Endogenous Opioid Function in Borderline Personality Disorder. Am J Psychiatry 2010;167:925-33. 33. Maremmani I, Pacini, M Pani, P. Effectiveness of buprenorphine in double diagnosed patients.Buprenorphine as psychothropic drug. Heroin Add & Rel Clin Probl 2006;8:31- 48. 34. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic Sensitivity to the Environment: The Case of The Serotonin Transporter Gene and its Implications for Studying Complex Diseases and Traits. Am J Psychiatry 2010;167:509-27. 35. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW et al. Role of Genotype in the Cycle of Violence in Maltreated Children. Sci 2002;297:851-4. 36. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene. Sci 2003;301:386-9. 37. Hariri AR, Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 2006;10(4):182-91. 38. Widiger TA, Mullins-Sweatt SN. Modelos categoriales y dimensionales de los trastornos de la personalidad. En: Oldman JM, Skodol AE, Bender DS editores. Tratado de los Trastornos de la Personalidad. Barcelona: Elsevier Masson;2007. p.37-55. 39. Gross C, Hen R. The Developmental Origins of Anxiety. Nature Rev Neurosci 2004;5:545-52. 40. Ni X, Chan K, Bulgin N, Sicard T, Bismil R, McMain Sh, Kennedy JL. Association between serotonin transporter gene and bordeline personality disorder. J Psychiatr Res 2006; 40:448-53. 41. New AS, Hazlett EA, Buchsbaum MS, Goodman M, Mitelman SA, Newmark R et al. Amygdala-Prefontal Disconnection in Borderline Personality Disorder. Neuropsycopharmacol 2007;32:1629-40. 42. Morris JS, Friston KJ, Büchel C, Frith CD, Young AW, Calder AJ et al. A neuromodulatory role for the human amygdala in processing emotional facial expressions. Nature 1998;383:812- 5. 43. Silbersweig D, Clarkin JF, Goldstein M, Kernberg OF, Tuescher O, Levy KN et al. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry 2007;164(12):1776-9. 44. Shmahl C, Douglas Bremmer J. Neuroimaging in borderline personality disorder. J Psychiatry Res 2006;40:419-27. 45. Francis D, Dorio J, Liu D, Meany MJ. Nongenomic Transmission Across Generations of Maternal Behavior and Stress Responses in the Rat. Sci 1999;286:1155-8. 16 // EDITORIAL SCIENS
Loading...
Loading...
Loading...
Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar
Editorial Sciens, Todos los Derechos Reservados 2015